Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14864300 | 1.00 | OGA (0.34) | OGACYP2D6THRBHSD17B10 | |
| SCHEMBL17590143 | 1.00 | OGA (0.34) | OGACYP2D6THRBHSD17B10 | |
| SCHEMBL17590151 | 1.00 | OGA (0.34) | OGACYP2D6THRBHSD17B10 | |
| SCHEMBL18854300 | 0.89 | OGA (0.38) | OGACYP2D6THRBHSD17B10 | |
| SCHEMBL15267319 | 0.89 | CYP2D6 (0.32) | OGACYP2D6THRBHSD17B10 | |
| SCHEMBL18385935 | 0.86 | CYP2D6 (0.43) | CYP2D6THRBHSD17B10 | |
| SCHEMBL18589166 | 0.86 | CYP2D6 (0.43) | CYP2D6THRBHSD17B10 | |
| SCHEMBL15975741 | 0.86 | CYP2D6 (0.43) | CYP2D6THRBHSD17B10 | |
| SCHEMBL16367886 | 0.86 | CYP2D6 (0.43) | CYP2D6THRBHSD17B10 | |
| SCHEMBL18589293 | 0.86 | CYP2D6 (0.43) | CYP2D6THRBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987430-B2 | Efficient and scalable process for the manufacture of fondaparinux sodium | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2015-03-24 | — | — | US | disclosed |
| US-20130261291-A1 | EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2013-10-03 | — | — | US | disclosed |
| US-20130102764-A1 | PROCESS FOR PERPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2013-04-25 | — | — | US | disclosed |
| US-8420790-B2 | Efficient and scalable process for the manufacture of Fondaparinux sodium | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2013-04-16 | — | — | US | disclosed |
| US-8288515-B2 | Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2012-10-16 | — | — | US | disclosed |
| US-20120116066-A1 | EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2012-05-10 | — | — | US | disclosed |
| US-20110105418-A1 | PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105418-A1 | PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | F11, TFPI, STS | OGA 155/4885CYP2D6 1099/4885THRB 3708/4885 |
| US-20130102764-A1 | PROCESS FOR PERPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | TFPI, PLG, PCSK6 | OGA 129/4885CYP2D6 1479/4885THRB 3176/4885 |
| US-20120116066-A1 | EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | F11, F10, F2 | OGA 448/4885CYP2D6 1093/4885THRB 4515/4885 |
| US-20130261291-A1 | EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | F11, F10, F2 | OGA 448/4885CYP2D6 1093/4885THRB 4515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.